STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS

Show other versions (1)

Bibliographic Details
Main Authors:	Mesker, W, Johnstone, E, Van Pelt, G, Midgley, R, Liefers, G, Morreau, J, Kerr, D, Tollenaar, R
Format:	Conference item
Published:	2010

Similar Items

Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients
by: Mesker, W, et al.
Published: (2010)

Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage I-II Colon Cancer Patients
by: Mesker, W, et al.
Published: (2011)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
by: Mesker, W, et al.
Published: (2010)

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
by: Huijbers, A, et al.
Published: (2013)

THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS
by: Mesker, W, et al.
Published: (2012)

Filling the gap between microscopic and automated analysis of the tumor-stroma ratio
by: Gabi Pelt, et al.
Published: (2020-03-01)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
by: Marloes A. Smit, et al.
Published: (2023-01-01)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
by: Cor J. Ravensbergen, et al.
Published: (2021-12-01)

Prognosis prediction of stage II colon cancer by gene expression profiling
by: Capella, MG, et al.
Published: (2007)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
by: Midgley, R, et al.
Published: (2013)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
by: Cor J. Ravensbergen, et al.
Published: (2021-10-01)

Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer
by: Takashi Okuyama, et al.
Published: (2020-09-01)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
by: G.W. van Pelt, et al.
Published: (2020-01-01)

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
by: Yong Chen, et al.
Published: (2020-12-01)

DSG2 expression is low in colon cancer and correlates with poor survival
by: Tingting Yang, et al.
Published: (2021-01-01)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
by: Midgley, R, et al.
Published: (2005)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute<it>⊕ </it>Study
by: Pruijt Hans FM, et al.
Published: (2011-05-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005)

High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
by: Elizabeth Morrow, et al.
Published: (2023-06-01)

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?
by: Kerr, D, et al.
Published: (2010)

Defective mismatch repair in colon cancer: A prognostic or predictive biomarker?
by: Kerr, D, et al.
Published: (2010)

Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels
by: Arentz Georgia, et al.
Published: (2011-12-01)

Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma
by: Giorgio Malpeli, et al.
Published: (2024-02-01)

Cancer of the Colon and Rectum: Treatment: Chemotherapy
by: Sabharwal, A, et al.
Published: (2009)

High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer
by: Sabine Hülsen, et al.
Published: (2020-11-01)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
by: Zeyan Xu, et al.
Published: (2021-10-01)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
by: Tanke Hans J, et al.
Published: (2010-04-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
by: Hannah Si Hui Lau, et al.
Published: (2023-10-01)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
by: Lau, Hannah Si Hui, et al.
Published: (2024)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
by: Hyeon Jeong Oh, et al.
Published: (2017-05-01)

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer
by: Dan Jiang, et al.
Published: (2021-09-01)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
by: Koukourakis, M, et al.
Published: (2003)

The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
by: Shahid Hussain, et al.
Published: (2020-12-01)

Prognostic factors of overall survival for patients with stage II colon cancer
by: Harsha Trivedi, et al.
Published: (2014-11-01)

The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
by: Yanghong Ni, et al.
Published: (2021-05-01)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
by: Karina Vázquez-Arreguín, et al.
Published: (2023-06-01)

Cancer cell survival depends on collagen uptake into tumor-associated stroma
by: Kuo-Sheng Hsu, et al.
Published: (2022-11-01)

Polarimetric biomarkers of peri-tumoral stroma can correlate with 5-year survival in patients with left-sided colorectal cancer
by: Jigar Lad, et al.
Published: (2022-07-01)

APC mutation correlated with poor response of immunotherapy in colon cancer
by: Bing Li, et al.
Published: (2023-03-01)

Biomarkers in early-stage colorectal cancer: ready for prime time?
by: Church, D, et al.
Published: (2012)